Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00006400Phase 3Completed
Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia
Anemia, Sickle CellHematologic Diseases
Principalinvestigator

Research Network

Collaboration Network

21 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Drexel University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rathi V. Iyer, MD

University of Mississippi Medical Center

Related
1 trials

Shared therapeutic areas:

Anemia, Sickle CellHematologic Diseases

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Sohail R. Rana, MD

Howard University

Related
1 trials

Shared therapeutic areas:

Anemia, Sickle CellHematologic Diseases

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

James F. Casella, MD

Johns Hopkins University

Related
2 trials

Shared therapeutic areas:

Anemia, Sickle CellHematologic Diseases

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Lori Luchtman-Jones, MD

Children's National Research Institute

Related
1 trials

Shared therapeutic areas:

Anemia, Sickle CellHematologic Diseases

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Courtney Thornburg, MD

Duke University

Related
2 trials

Shared therapeutic areas:

Anemia, Sickle CellHematologic Diseases

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Sharada Sarnaik, MD

Wayne State University

Related
1 trials

Shared therapeutic areas:

Anemia, Sickle CellHematologic Diseases

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Sherron Jackson, MD

Medical University of South Carolina

Related
1 trials

Shared therapeutic areas:

Anemia, Sickle CellHematologic Diseases

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Zora R. Rogers, MD

University of Texas SW Medical Center

Related
1 trials

Shared therapeutic areas:

Anemia, Sickle CellHematologic Diseases

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

R. Clark Brown, MD, PhD

Emory University

Related
1 trials

Shared therapeutic areas:

Anemia, Sickle CellHematologic Diseases

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Winfred C. Wang, MD

St. Jude Children's Research Hospital

Related
2 trials

Shared therapeutic areas:

Anemia, Sickle CellHematologic Diseases

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score24%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00006400Phase 3PrincipalInvestigator

Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell Anemia

Anemia, Sickle CellHematologic Diseases
Completed

All 1 trials loaded